|
Synonyms: compound 2 [PMID: 42460925]
Compound class:
Synthetic organic
Comment: VU6081679 is a CNS penetrant and orally bioavailable metabotropic glutamate receptor 8 (mGlu8) positive allosteric modulator [1]. It binds to an allosteric site at the extracellular TM6/TM7 dimer interface.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
|||||||||||||||||||||||||||||||||||
| References |
|
1. Richardson AE, Ferranti AS, Peng L, Lei X, Han A, Qi A, Rodriguez AL, Chang S, Sant S, Zagol-Ikapitte I et al.. (2026)
Discovery of VU6081679, a Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor 8 with Efficacy in a Preclinical Model of Parkinson's Disease. ACS Chem Neurosci, [Epub ahead of print]. [PMID:42460925] |